Global events can have a profound impact on all industries, with the pharmaceutical industry ... transparency and integrating supply chain risk management into your governance and leadership ...

BioMarin Pharmaceutical Inc. ( NASDAQ: BMRN) Q4 2024 Earnings Conference Call February 19, 2025 4:30 PM ET Traci McCarty - Head of IR Alexander Hardy - President and CEO Brian Mueller - EVP and CFO ...

subjects healthcare and pharmaceutical manufacturers to strict cybersecurity mandates. Gaps, however, still exist. In the EU, 10% of companies in the sector lack a vulnerability management plan ...

In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing AVT29, a biosimilar candidate for Eylea ® HD (aflibercept) 8 mg. Teva also ...

Moveworks, the leading agentic AI assistant for the enterprise, today announced that it has achieved Federal Risk and Authorization Management Program (FedRAMP®) Ready status and is now listed in the ...

SELARSDI is approved for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adults and pediatric patients 6 years and older, and the treatment of adult patients ...

The rise in human life expectancy has slowed down across Europe since 2011, according to research from the University of East Anglia and partners. A new study, published today in The Lancet Public ...

Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the "Company”), a pharmaceutical company focused on developing new ...

Allurion Technologies, Inc. ("Allurion" or the "Company") , a company dedicated to ending obesity, today announced its intention to initiate a clinical study on the combination of the Allurion Balloon ...

The essential steps to obtain a CPAP machine for sleep apnea, including prescription requirements, costs, insurance coverage, ...